New, Cheap, and Improved
Report from Global Health Program
Report from Global Health Program

New, Cheap, and Improved

Assessing the Promise of Reverse and Frugal Innovation to Address Noncommunicable Diseases

June 2015

Report

Overview

In recent years, frugal and reverse innovation have gained attention as potential strategies for increasing the quality and accessibility of health care while slowing the growth in its costs. The notion that health technologies, services, and delivery processes developed for low-income customers in low-resource settings (known as "frugal innovations") might also prove useful in other countries and higher-income settings (a process some call "reverse innovation") is not new.  The demand for these types of innovation is increasing, however, as developed and developing countries alike strain to cope with the staggering economic and social costs of noncommunicable diseases (NCDs).

Thomas J. Bollyky

Bloomberg Chair in Global Health; Senior Fellow for International Economics, Law, and Development; and Director of the Global Health Program

Increased attention on innovation is welcome—particularly when it is in service of improving the economic opportunities of the world's poorest and increasing their access to much-needed health-care products and services. The trick will be to ensure that the focus on reverse and frugal innovation goes beyond the latest buzzword and translates into real investments and results. With this goal in mind, this paper seeks to answer three practical questions regarding reverse and frugal innovation and NCDs:

More on:

Noncommunicable Diseases

Technology and Innovation

Competitiveness

  • Are reverse and frugal innovations likely to be important for addressing the NCD challenges facing the poor in high- and low-income settings?
  • Which pressing NCD challenges are reverse and frugal innovations best suited to help solve?
  • What measures can donors, private companies, and nongovernmental organizations (NGOs) take to facilitate the use of reverse and frugal innovations to solve those problems?

The answers to these questions may contribute to the ongoing efforts of donors, investors, NGOs, and governments to move frugal and reverse innovation out of the realm of promising ideas and anecdotes and into broader practice to tackle the global challenge of NCDs.

More on:

Noncommunicable Diseases

Technology and Innovation

Competitiveness

Top Stories on CFR

Russia

Liana Fix, a fellow for Europe at CFR, and Thomas Graham, a distinguished fellow at CFR, sit down with James M. Lindsay to discuss the future of U.S. policy toward Russia and the risks posed by heightened tensions between two nuclear powers. This episode is the first in a special TPI series on the U.S. 2024 presidential election and is supported by the Carnegie Corporation of New York.

Terrorism and Counterterrorism

Violence around U.S. elections in 2024 could not only destabilize American democracy but also embolden autocrats across the world. Jacob Ware recommends that political leaders take steps to shore up civic trust and remove the opportunity for violence ahead of the 2024 election season.

China

Those seeking to profit from fentanyl and governments seeking to control its supply are locked in a never-ending competition, with each new countermeasure spurring further innovation to circumvent it.